1Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional nonaspirin non-steroidal anti-inflammatory drugs, aspirin and combinations[J]. Gut, 2006, 55(12): 1731-1738.
2Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based casecontrol study[J]. BMJ, 2006, 333(7571):726-729.
3Goldstein JL, Johanson JF, Suchower LJ, et al. Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial[J]. Am J Gastroenterol, 2005, 100(12):2650-2657.
4Goldstein JL, Miner PB Jr, Schlesinger PK, et al. Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole[J]. Aliment Pharmacol Ther, 2006, 23(8):1189-1196.
5Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding[J]. N Engl J Med, 2005, 352(3):238-244.
6Verhamme K, Mosis G, Dieleman J, et al. Spironolactone and risk of upper gastrointestinal events: population based case-control study[J]. BMJ, 2006,333(7563):330-338.
7Meijer WE, Heerdink ER, Nolen WA, et al. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants[J]. Arch Intern Med,2004, 164(21):2367-2370.
7Yiling Cheng , Caroline AM, Doroty RD, et al. Does physical activity reduce the risk of developing pepticulcers[ J] . Br J Sports Med, 2000,34:116 - 121.
8ANDERSEN IB JORGENSEN T, BDNNEV IE O, et al. Smoking and alcohol in take as risk factors for bleeding and perfomated peptic ulcersa population based cohort study [ J ] . Epididemiogy, 2000,11:434 - 439.
